Bellevue Life Sciences Acquisition Corp - Warrants (09/02/2028)
BLACW
Get informed when a big investor buys or sells
+ FollowMarket Cap$6.98M
Close$
Share Statistics
| Market cap | $6.98 Million |
|---|---|
| Enterprise Value | $5.93 Million |
| Dividend Yield | $NaN (NaN%) |
| Earnings per Share | $- |
| Beta | - |
| Outstanding Shares | - |
Return
| Return on Equity | 6.22% |
|---|---|
| Return on Assets | 4.60% |
| Return on Invested Capital | -14.83% |
Valuation & Multiples
| P/E Ratio | - |
|---|---|
| PEG | - |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 2.26 |
| Enterprise Value to EBIT | -0.26 |
| Enterprise Value to Net Income | 0 |
| Total Debt to Enterprise | 0.09 |
| Debt to Equity | 0 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Bellevue Life Sciences Acquisition Corp
2 employees